A school-age child with allergic rhinitis has persistent symptoms despite non-sedating antihistamines. What is the best step to manage this season’s symptoms?

A school-age child with allergic rhinitis has persistent symptoms despite non-sedating antihistamines. What is the best step to manage this season’s symptoms?

• A. Order an intranasal corticosteroid to begin 1 to 2 weeks prior to pollen season.
• B. Prescribe a decongestant medication as adjunct therapy during pollen season.
• C. Recommend adding diphenhydramine to the regimen for additional relief.
• D. Suggest using an over-the-counter intranasal decongestant.

Answer: (A)

Starting intranasal corticosteroids is the best step because they are the most effective long-term controller for allergic rhinitis, addressing multiple nasal symptoms such as congestion, sneezing, itching, and rhinorrhea. Using them regularly before the pollen season begins helps prevent symptom buildup and often reduces the need for other medications. In children, this preventive, anti-inflammatory approach has strong evidence and a favorable safety profile when used as directed. Decongestants, whether oral or intranasal, mainly provide short-term relief and can cause rebound congestion or systemic effects, making them less suitable for ongoing control or use in kids. Adding a sedating antihistamine like diphenhydramine brings extra risks of daytime sleepiness and anticholinergic effects, and it’s not as effective for nasal inflammation as intranasal steroids. Over-the-counter intranasal decongestants share the rebound concern and are not ideal for routine management.

Starting intranasal corticosteroids is the best step because they are the most effective long-term controller for allergic rhinitis, addressing multiple nasal symptoms such as congestion, sneezing, itching, and rhinorrhea. Using them regularly before the pollen season begins helps prevent symptom buildup and often reduces the need for other medications. In children, this preventive, anti-inflammatory approach has strong evidence and a favorable safety profile when used as directed.

Decongestants, whether oral or intranasal, mainly provide short-term relief and can cause rebound congestion or systemic effects, making them less suitable for ongoing control or use in kids. Adding a sedating antihistamine like diphenhydramine brings extra risks of daytime sleepiness and anticholinergic effects, and it’s not as effective for nasal inflammation as intranasal steroids. Over-the-counter intranasal decongestants share the rebound concern and are not ideal for routine management.